Improvement of cutaneous inflammation and panniculitis in patients with dermatomyositis by the Janus kinase inhibitor baricitinib

Autor: Fischer, Kristina, Aringer, Martin, Steininger, Julian, Heil, Julius, Beissert, Stefan, Abraham, Susanne, Günther, Claudia

Dear Editor, Dermatomyositis (DM) is a rare autoimmune disease with cutaneous and systemic involvement significantly impairing quality of life. Current treatment options are unspecific and often induce only partial remission, especially in DM‐assoc

Externí odkaz: https://tud.qucosa.de/id/qucosa%3A92097
https://tud.qucosa.de/api/qucosa%3A92097/attachment/ATT-0/

Ein neunjähriger Junge mit lichenoiden Hautveränderungen.

Autor: Lehr, Sophia, Aschoff, Roland, Blau, Kristin, Heil, Julius, Heyne, Stefanie, Beissert, Stefan, Günther, Claudia

Publikováno v: Journal der Deutschen Dermatologischen Gesellschaft; Jan2023, Vol. 21 Issue 1, p77-80, 4p

Improvement of cutaneous inflammation and panniculitis in patients with dermatomyositis by the Janus kinase inhibitor baricitinib.

Autor: Fischer K; Department of Dermatology., Aringer M; Department of Medicine III, Rheumatology; Medical Faculty Carl Gustav Carus, Technical University Dresden, Dresden, Germany., Steininger J; Department of Dermatology., Heil J; Department of Dermatology., Beissert S; Department of Dermatology., Abraham S; Department of Dermatology., Günther C; Department of Dermatology.

Publikováno v: The British journal of dermatology [Br J Dermatol] 2022 Sep; Vol. 187 (3), pp. 432-435. Date of Electronic Publication: 2022 May 20.